The PennZone

  • Home
  • Business
  • Non-profit
  • Health
  • Technology
  • Real Estate
  • Entertainment
  • Travel
  • Manufacturing

SafeBreak® Vascular Cleared for Pediatrics
The PennZone/10232295

Trending...
  • Wala Blegay to Announce Run for Congress in Maryland's 5th District on Feb. 4
  • Luxury Lake-View Home Launches in Kissimmee's Bellalago community, Offering Privacy, Space, and Florida Resort-Style Living
  • Nashville International Chopin Piano Competition Launches First Amateur Edition
SafeBreak Vascular installed on a pediatric line SafeBreak Vascular installed on a pediatric line SafeBreak Vascular installed on a pediatric line Lineus Medical
FAYETTEVILLE, Ark. - PennZone -- Lineus Medical, a medical device company focused on reducing IV complications, announced that the company's flagship product, SafeBreak Vascular, has received clearance from the U.S. Food and Drug Administration (FDA) for use in pediatric patients. SafeBreak Vascular has been shown in adult clinical studies to reduce IV complications with its innovative breakaway technology1.

SafeBreak Vascular is the first breakaway device cleared by the FDA and proven to reduce IV complications in adults by 44%1. It fits between the IV tubing from the IV pump and the patient's IV access point at the arm. When there is a damaging force on the line, SafeBreak separates to protect the patient's IV. This innovative feature helps prevent accidental dislodgement of the catheter, as well as other IV complications caused by damaging forces on the IV line1. This is especially important for pediatric patients who may be more active, less inclined to follow instructions, and less aware of their surroundings.

More on The PennZone
  • Finland's Health Authority Launches '2-4-2' Gambling Risk Limits Ahead of Expected Advertising Boom
  • Dr. Billy B. Laun II Addresses Over 120 Dental Professionals at Annual Dental Meeting
  • CCHR: Taxpayer Billions Wasted on Mental Health Research as Outcomes Deteriorate
  • Digital Efficiency Consulting Group (DECG) Officially Launches
  • Work 365 Delivers Purpose-Built Revenue Operations for Microsoft Cloud for US Government

"We are incredibly proud to receive clearance from the FDA for the use of SafeBreak Vascular with pediatric patients," said Vance Clement, CEO of Lineus Medical. "SafeBreak provides a simple, effective solution for preventing IV complications, which reduces IV restarts and additional needlesticks for patients.  Now, it doesn't matter if the patient is 1 or 100 years old, SafeBreak is cleared for use on all peripheral IVs.  Our goal is to have a SafeBreak on every IV line, everywhere in the world, and this additional clearance lets us help one of the most vulnerable populations that needs it the most, our kids."

ABOUT LINEUS MEDICAL

Lineus Medical is the developer of a unique, patented, break-away technology that is designed to work with all types of medical tubing. Complications with feeding tubes, IV lines, urinary catheters and any other type of medical tubing may be reduced as breakaway devices separate to protect the patient. More information about Lineus Medical can be found on the company website:  www.lineusmed.com or you can follow the company on Twitter or LinkedIn.

1 Dipper Study Data on File

MKG-0194 REV 00

Contact
Vance Clement
***@lineusmed.com


Source: Lineus Medical

Show All News | Report Violation

0 Comments
1000 characters max.

Latest on The PennZone
  • Blasting Off with Space Sector Companies: Artemis II Manned Moon Mission is Set to Launch: Could $ASTI be on the Same Rocket Ride as $ASTS & $LUNR?
  • Costa Oil Named Primary Sponsor of Carson Ware for the United Rentals 300 at Daytona International Speedway
  • HBMHCW Expande Infraestructura de Cumplimiento para Argentina mientras América Latina Supera $1.5 Billones en Volumen Cripto
  • Norisia Launches AI Formulated Luxury Multivitamin to Transform Daily Wellness in the UK
  • Jacob Emrani's Annual "Supper Bowl" Expected To Donate Thousands Of Meals
  • NASA / Glenn Research Center Collaboration to Help Meet Rising Demand for Space Energy Beaming Tech / CIGS PV Modules from Ascent Solar: NAS DAQ: ASTI
  • When Interpretation Becomes Conversation: Rethinking Engagement in the Museum Age
  • Half of Finnish Online Gambling Expenditure Now Flows to Offshore Instant Casinos as License Applications Open March 1, 2026
  • RTC Communications Completes Next Level Connect Fiber Expansion Bringing Multi-Gig Broadband to West Boggs Community
  • EPP Pricing Platform announces leadership transition to support long-term growth and continuity
  • Stolen Hearts: Reclaiming Your Child From Parental Alienation (narcissistic abuse)
  • Roshni Online Services Unveils Plans for Innovative Digital Consultation Platform
  • VIP Vacations Named Winner Of The Knot Best Of Weddings 2026
  • Wall Street Is Missing This One: Cycurion (NAS DAQ: CYCU) Gets $7 Price Target While Trading at a Steep Discount
  • Aries Industries Streamlines Sewer Inspection Process With Introduction of the LETS Sidewinder
  • Visit Potter-Tioga Executive Director Appointed to Statewide Tourism Leadership Position
  • Chronic Boss Awards Scholarships to Student Founders Living with Chronic Conditions
  • Nest Finders Property Management Named #1 in Jacksonville and Ranked #99 Nationwide
  • Nashville International Chopin Piano Competition Launches First Amateur Edition
  • Anatomy Naturals Earns Industry Recognition for Small-Batch Botanical Skincare

Popular on PennZone

  • Mark Schork Selected As 'Board Observer' By Philadelphia Bar Foundation - 133
  • Food Journal Magazine Releases Its 'Best Food In Los Angeles Dining' Editorial Section
  • High-End Exterior House Painting in Boulder, Colorado
  • Michael Judkins Releases New Poetry Book, Deeper Than You Think
  • New Year, New Home: Begin 2026 at Heritage at South Brunswick
  • Acmeware and Avo Partner to Bring Real-Time Data Integration to MEDITECH Customers
  • $780,000 Project for New Middle East Police Service with Deposit Received and Preliminary Design Work Underway for Lamperd: Stock Symbol: LLLI
  • High-Impact Mental Health Platform Approaching a Defining Regulatory Moment: Eclipsing 70,000 Patients on Real World Use of Ketamine: N ASDAQ: NRXP
  • Rande Vick Introduces Radical Value, Challenging How Brands Measure Long-Term Value
  • Report Outlines Key Questions for Individuals Exploring Anxiety Treatment Options in Toronto

Similar on PennZone

  • Joan Nissen promoted to Century Fasteners Corp. – General Manager, Aerospace & Government Sales
  • NRE-HEALTH Radio Launches With a New Approach to Health Broadcasting
  • From Coffee to Commutes: sMiles App Now Pays Bitcoin for Every Gift Card Purchase
  • Dr. Billy B. Laun II Addresses Over 120 Dental Professionals at Annual Dental Meeting
  • CCHR: Taxpayer Billions Wasted on Mental Health Research as Outcomes Deteriorate
  • Meridianvale Unveils QarvioFin Public Beta: The First 'Glass Box' AI Operating System for Autonomous Finance
  • Mend Colorado Launches Revamped Sports Performance Training Page
  • Parkway Prosthodontics Achieves Breakthrough Full-Arch Reconstruction Case
  • Postmortem Pathology Expands to Phoenix: Bringing Families Answers During Their Most Difficult Moments
  • Blasting Off with Space Sector Companies: Artemis II Manned Moon Mission is Set to Launch: Could $ASTI be on the Same Rocket Ride as $ASTS & $LUNR?
Copyright © The PennZone | Theme: OMag by LilyTurf Themes
  • Contribute
  • Privacy Policy
  • Terms of Service
  • Contact Us